213 related articles for article (PubMed ID: 1402647)
21. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
Xu M; Jackson R; Adams S; Humphreys RE
Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
Negroni MP; Stern LJ
PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
[TBL] [Abstract][Full Text] [Related]
23. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
[TBL] [Abstract][Full Text] [Related]
24. Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules.
Johansen BH; Gedde-Dahl T; Sollid LM; Vartdal F; Thorsby E; Gaudernack G
Scand J Immunol; 1994 Jun; 39(6):607-12. PubMed ID: 8009176
[TBL] [Abstract][Full Text] [Related]
25. Peptides on phage: a vast library of peptides for identifying ligands.
Cwirla SE; Peters EA; Barrett RW; Dower WJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6378-82. PubMed ID: 2201029
[TBL] [Abstract][Full Text] [Related]
26. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
Jardetzky TS; Gorga JC; Busch R; Rothbard J; Strominger JL; Wiley DC
EMBO J; 1990 Jun; 9(6):1797-803. PubMed ID: 2189723
[TBL] [Abstract][Full Text] [Related]
27. Identification of a biologically significant DNA-binding peptide motif by use of a random phage display library.
Cheng X; Kay BK; Juliano RL
Gene; 1996 May; 171(1):1-8. PubMed ID: 8675015
[TBL] [Abstract][Full Text] [Related]
28. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.
DiBrino M; Parker KC; Shiloach J; Knierman M; Lukszo J; Turner RV; Biddison WE; Coligan JE
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1508-12. PubMed ID: 7679507
[TBL] [Abstract][Full Text] [Related]
29. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
[TBL] [Abstract][Full Text] [Related]
30. The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library.
Gregori S; Bono E; Gallazzi F; Hammer J; Harrison LC; Adorini L
Int Immunol; 2000 Apr; 12(4):493-503. PubMed ID: 10744651
[TBL] [Abstract][Full Text] [Related]
31. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
[TBL] [Abstract][Full Text] [Related]
32. A novel approach to human anti-HLA mABs production: use of phage display libraries.
Pistillo MP; Hammer J; Bono E; Sinigaglia F; Bottero F; Gho A; Ferrara GB
Hum Immunol; 1997 Sep; 57(1):19-26. PubMed ID: 9438191
[TBL] [Abstract][Full Text] [Related]
33. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
[TBL] [Abstract][Full Text] [Related]
34. An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets.
Kay BK; Adey NB; He YS; Manfredi JP; Mataragnon AH; Fowlkes DM
Gene; 1993 Jun; 128(1):59-65. PubMed ID: 8508960
[TBL] [Abstract][Full Text] [Related]
35. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):734-8. PubMed ID: 8570625
[TBL] [Abstract][Full Text] [Related]
36. Random peptide libraries: a source of specific protein binding molecules.
Devlin JJ; Panganiban LC; Devlin PE
Science; 1990 Jul; 249(4967):404-6. PubMed ID: 2143033
[TBL] [Abstract][Full Text] [Related]
37. Using a neural network to identify potential HLA-DR1 binding sites within proteins.
Bisset LR; Fierz W
J Mol Recognit; 1993 Mar; 6(1):41-8. PubMed ID: 8251191
[TBL] [Abstract][Full Text] [Related]
38. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
Stratikos E; Mosyak L; Zaller DM; Wiley DC
J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
40. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.
Urban RG; Chicz RM; Strominger JL
J Exp Med; 1994 Aug; 180(2):751-5. PubMed ID: 8046351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
